WebDec 10, 2015 · Inception IBD is the sixth spinoff of San Diego-based Inception Sciences, a 70-employee operation Versant runs to incubate academic ideas and turn them into biotech startups—often, “build to ... WebMar 10, 2024 · Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The …
U.S.-Based Versant Ventures Dumps $10 Million Into Vancouver ... - BioSpace
WebNov 4, 2011 · The collaboration utilizes an innovative funding structure between Quanticel, Celgene and Versant Ventures. Versant and Celgene have worked together to capitalize Quanticel at an early juncture, providing Versant with a strategic partner and potential acquirer, and Celgene with early and exclusive access to an R&D engine capable of … WebDec 10, 2013 · Versant has committed a $10 million Series A to a new company called Inception 4 that will be managed by the Vancouver-based biotech team. “We are investing in B.C. to develop early-stage companies because we know there is exceptional research talent and leading academic research in the province,” said Brad Bolzon PhD., managing director … philosophe austin
In New York and Montreal, Versant Seeds Two New Biotech Startups …
WebOct 31, 2024 · Ophthotech Corporation (NasdaqGS:OPHT) acquired Inception 4, Inc. from Versant Side Fund IV, L.P. and Versant Venture Capital IV, L.P. managed by Versant Venture Management, LLC for approximately $120 million on October 30, 2024. In connection with the closing, Ophthotech issued 5 million shares of its common stock to the former equity … WebApr 13, 2016 · Jerel demonstrated leadership for Versant’s global investment strategy, built a deep network within several world-class academic institutes and established operating sites for the firm in Vancouver, Toronto and Montreal. He will continue to operate from the Versant Vancouver office, co-located with one of the Inception Sciences research sites. WebMar 21, 2024 · Ophthotech Corporation announced that it has acquired Inception 4, a privately held company backed by Versant Ventures, expanding Ophthotech’s therapeutic pipeline in age-related retinal indications. Through this acquisition, Ophthotech gains worldwide development and commercialization rights to Inception 4’s small molecule … tsh 17.3